84 related articles for article (PubMed ID: 19423163)
1. Malignant hematopoietic cell lines: in vitro models for the study of plasmacytoid dendritic cell leukemia.
Drexler HG; Macleod RA
Leuk Res; 2009 Sep; 33(9):1166-9. PubMed ID: 19423163
[No Abstract] [Full Text] [Related]
2. A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cells.
Narita M; Watanabe N; Yamahira A; Hashimoto S; Tochiki N; Saitoh A; Kaji M; Nakamura T; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Leuk Res; 2009 Sep; 33(9):1224-32. PubMed ID: 19443030
[TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Garnache-Ottou F; Feuillard J; Saas P
Br J Haematol; 2007 Feb; 136(4):539-48. PubMed ID: 17367408
[TBL] [Abstract][Full Text] [Related]
4. Skin lesions in plasmacytoid dendritic cell leukaemia.
Whittle AM; Howard MR
Br J Haematol; 2008 Jan; 140(2):121. PubMed ID: 17991299
[No Abstract] [Full Text] [Related]
5. [Plasmacellular leukemia. Anatomoclinical study of a case].
Piaserico PL; Dalla Pria AF
Arch De Vecchi Anat Patol; 1976 Dec; 61(3):503-19. PubMed ID: 71879
[No Abstract] [Full Text] [Related]
6. The use of cell lines for the study of Waldenström's macroglobulinemia.
Gertz M; Ansell S
Leuk Res; 2008 Nov; 32(11):1648-9. PubMed ID: 18533257
[TBL] [Abstract][Full Text] [Related]
7. Application of interleukin-12 expressing dendritic cells for the treatment of animal model of leukemia.
Tsai BY; Lin YL; Chiang BL
Exp Biol Med (Maywood); 2009 Aug; 234(8):952-60. PubMed ID: 19491372
[TBL] [Abstract][Full Text] [Related]
8. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
[TBL] [Abstract][Full Text] [Related]
9. [Tumor cells lysates pulsed dendritic cells for immunotherapy of ovarian cancer in rats: in-vitro study].
Zhai Y; Zhang ZY; Wang SZ; Qiao BL; Liu JW
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):635-40. PubMed ID: 19595166
[TBL] [Abstract][Full Text] [Related]
10. Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.
Riboldi E; Daniele R; Cassatella MA; Sozzani S; Bosisio D
Immunobiology; 2009; 214(9-10):868-76. PubMed ID: 19577819
[TBL] [Abstract][Full Text] [Related]
11. Philadelphia chromosome-positive blastic plasmacytoid dendritic cell leukemia.
Adams RL; McCarthy C; Bird RJ
Cancer Genet Cytogenet; 2009 Dec; 195(2):186-8. PubMed ID: 19963123
[No Abstract] [Full Text] [Related]
12. Primary plasma cell leukemia with initial cutaneous involvement and IgA biclonal gammopathy.
Chattopadhyay A; Nath UK; De R; Singh A; Sanyal S; Chatterjee SK; Chaudhuri U
Ann Hematol; 2008 Mar; 87(3):249-51. PubMed ID: 17909800
[No Abstract] [Full Text] [Related]
13. [Leukemic dendritic cells].
Gal'tseva IV; Pashin LE; Savchenko VG
Ter Arkh; 2008; 80(7):84-8. PubMed ID: 18763607
[No Abstract] [Full Text] [Related]
14. Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: a case report.
Olivieri A; Attolico I; Cimminiello M; Discepoli G; Cifarelli RA
Leuk Res; 2009 Nov; 33(11):e191-3. PubMed ID: 19476997
[No Abstract] [Full Text] [Related]
15. Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review.
Tucci M; Ciavarella S; Strippoli S; Dammacco F; Silvestris F
Ann N Y Acad Sci; 2009 Sep; 1173():449-57. PubMed ID: 19758185
[TBL] [Abstract][Full Text] [Related]
16. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis.
Hartigan AJ; Westwick J; Jarai G; Hogaboam CM
J Immunol; 2009 Oct; 183(8):5171-9. PubMed ID: 19783686
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell leukaemia cutis preferentially localized to recent puncture sites.
Kim JE; Kim MY; Kim HO; Park YM
Br J Dermatol; 2004 Jul; 151(1):237-8. PubMed ID: 15270902
[No Abstract] [Full Text] [Related]
18. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
[TBL] [Abstract][Full Text] [Related]
19. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
Miyake T; Kumagai Y; Kato H; Guo Z; Matsushita K; Satoh T; Kawagoe T; Kumar H; Jang MH; Kawai T; Tani T; Takeuchi O; Akira S
J Immunol; 2009 Aug; 183(4):2522-8. PubMed ID: 19635904
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
